325 related articles for article (PubMed ID: 1538132)
41. Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes.
Rodriguez C; Afchain D; Capron A; Dissous C; Santoro F
Eur J Immunol; 1985 Jul; 15(7):747-9. PubMed ID: 2408905
[TBL] [Abstract][Full Text] [Related]
42. Leishmania major infection in mice primes for specific major histocompatibility complex class I-restricted CD8+ cytotoxic T cell responses.
da Conceição-Silva F; Perlaza BL; Louis JA; Romero P
Eur J Immunol; 1994 Nov; 24(11):2813-7. PubMed ID: 7957573
[TBL] [Abstract][Full Text] [Related]
43. Toxoplasma gondii RH Ankara: production of evolving tachyzoites using a novel cell culture method.
Değirmenci A; Döşkaya M; Caner A; Ciçek C; Korkmaz M; Gürüz Y; Uner A
Exp Parasitol; 2011 May; 128(1):1-8. PubMed ID: 21296077
[TBL] [Abstract][Full Text] [Related]
44. Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.
Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Nishitani M; Ishikawa H; Himeno K
Immunology; 2001 Nov; 104(3):289-98. PubMed ID: 11722643
[TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii.
Tan F; Hu X; Pan CW; Ding JQ; Chen XG
Parasitol Int; 2010 Jun; 59(2):141-6. PubMed ID: 20056166
[TBL] [Abstract][Full Text] [Related]
46. Toxoplasma gondii antigens: recovery analysis of tachyzoites cultivated in Vero cell maintained in serum free medium.
da Costa-Silva TA; da Silva Meira C; Frazzatti-Gallina N; Pereira-Chioccola VL
Exp Parasitol; 2012 Apr; 130(4):463-9. PubMed ID: 22306070
[TBL] [Abstract][Full Text] [Related]
47. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
[TBL] [Abstract][Full Text] [Related]
48. Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of
Sa Q; Ochiai E; Tiwari A; Mullins J; Shastri N; Mercier C; Cesbron-Delauw MF; Suzuki Y
J Immunol; 2017 Jun; 198(11):4425-4434. PubMed ID: 28446567
[No Abstract] [Full Text] [Related]
49. Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin 2 production and macrophage-mediated inhibitory effects.
Haque S; Khan I; Haque A; Kasper L
Infect Immun; 1994 Jul; 62(7):2908-16. PubMed ID: 8005679
[TBL] [Abstract][Full Text] [Related]
50. Rhoptry and Dense Granule Secreted Effectors Regulate CD8
Rommereim LM; Fox BA; Butler KL; Cantillana V; Taylor GA; Bzik DJ
Front Immunol; 2019; 10():2104. PubMed ID: 31555296
[No Abstract] [Full Text] [Related]
51. Toxoplasma gondii antigens GRA1 (p24) and SAG1 (p30): a comparison of their stimulatory influence on T-cell activation and cytokine expression in in vitro cultures.
Kato M; Claveria FG; Maki Y; Tanaka T; Suzuki N; Nagasawa H
Pathobiology; 2005; 72(3):160-4. PubMed ID: 15860934
[TBL] [Abstract][Full Text] [Related]
52. Cytokine production of CD8+ immune T cells but not of CD4+ T cells from Toxoplasma gondii-infected mice is polarized to a type 1 response following stimulation with tachyzoite-infected macrophages.
Miller R; Wen X; Dunford B; Wang X; Suzuki Y
J Interferon Cytokine Res; 2006 Nov; 26(11):787-92. PubMed ID: 17115896
[TBL] [Abstract][Full Text] [Related]
53. [Role of CD8+ T cells in the tumor growth delay induced by Toxoplasma gondii excreted-secreted antigen in B16F10 mouse melanoma model].
Jiao YM; Fang Q; Xia H; Wang XM; Tao ZY; Chen XZ; Shen JL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Apr; 31(2):95-8. PubMed ID: 24809186
[TBL] [Abstract][Full Text] [Related]
54. Cellular and humoral recognition of Toxoplasma gondii P30 antigen and its cleavage fragments.
Velge-Roussel F; Chardès T; Mevelec P; Bout D
Ann Rech Vet; 1992; 23(3):291-2. PubMed ID: 1384417
[No Abstract] [Full Text] [Related]
55. [Antigen analysis of Toxoplasma gondii lysate and excretory-secretory materials by enzyme-linked immunoelectrotransfer blot (EITB)].
Ahn MH; Son HJ; Leem MH; Min DY
Korean J Parasitol; 1994 Dec; 32(4):249-57. PubMed ID: 7834242
[TBL] [Abstract][Full Text] [Related]
56. [Purification of Toxoplasma gondii Tachyzoites with cellulose membrane filtration and preparation of soluble antigen].
Fang ZM; Wang S; Su BT; Gong NQ; Liu WQ; Ming CS
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):329-31. PubMed ID: 21351541
[TBL] [Abstract][Full Text] [Related]
57. Aging and the immune response. II. Lymphocyte responsiveness and macrophage activation in Toxoplasma gondii-infected mice.
Gardner ID; Remington JS
J Immunol; 1978 Mar; 120(3):944-9. PubMed ID: 632594
[No Abstract] [Full Text] [Related]
58. The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival.
Tuladhar S; Kochanowsky JA; Bhaskara A; Ghotmi Y; Chandrasekaran S; Koshy AA
PLoS Pathog; 2019 Oct; 15(10):e1007856. PubMed ID: 31648279
[TBL] [Abstract][Full Text] [Related]
59. Respective role of antibodies and immune macrophages during acquired immunity against toxoplasmosis in mice.
Stadtsbaeder S; Nguyen BT; Calvin-Preval MC
Ann Immunol (Paris); 1975; 126C(4):461-74. PubMed ID: 1211881
[TBL] [Abstract][Full Text] [Related]
60. The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii.
Rachinel N; Buzoni-Gatel D; Dutta C; Mennechet FJ; Luangsay S; Minns LA; Grigg ME; Tomavo S; Boothroyd JC; Kasper LH
J Immunol; 2004 Aug; 173(4):2725-35. PubMed ID: 15294991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
